Patent ID: 7871778

Claim:
A method of providing a prognosis for endometriosis, the method comprising the steps of: obtaining a biological sample from a human subject suspected of or having endometriosis, detecting, in the biological sample altered expression (over or under expression of at least 50%) of a gene or protein wherein said altered expression is selected from the group consisting of over expression of the S100 calcium binding protein A8 (S100A8) gene or protein, under expression of the Indian hedgehog (IHH) gene or protein, over expression of the proenkephalin (PENK) gene or protein, under expression of the cytochrome P450 subfamily XXVIA (Cyp26A1) gene or protein, under expression of the leukotriene B4 receptor (BLTR2) gene or protein, under expression of the mitogen-activated protein kinase 4 (MAPK4) gene or protein, under expression of the secretoglobin family 2A, member 2 (SCGB2A2) gene or protein, under expression of the calpain 6 (CAPN6) gene or protein, and under expression of the mitogen-inducible gene 6 (MIG6) or protein, wherein the altered expression correlates with the prognosis for endometriosis, and the prognosis is provided.